Schafer Carol
SEC-identified person · CIK 1272181 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Immunome Inc. IMNM | Director | filed 2024 - 2026 |
| Zeta Acquisition Corp III KURO | Director | filed 2021 - 2026 |
| Insmed Inc INSM | Director | filed 2020 - 2026 |
| Repare Therapeutics Inc. RPTX | Director | filed 2020 - 2026 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2018 - 2022 |
| Five Prime Therapeutics, INC. FPRX | Director | filed 2019 - 2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.